Tower Research Capital (TRC)’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,364
| Closed | -$21.5K | – | 6121 |
|
|
2024
Q1 | $21.5K | Sell |
1,364
-7,112
| -84% | -$112K | ﹤0.01% | 2939 |
|
|
2023
Q4 | $137K | Buy |
8,476
+7,255
| +594% | +$117K | ﹤0.01% | 2395 |
|
|
2023
Q3 | $15.5K | Sell |
1,221
-5,596
| -82% | -$71.2K | ﹤0.01% | 3608 |
|
|
2023
Q2 | $96K | Buy |
6,817
+4,024
| +144% | +$56.7K | ﹤0.01% | 2031 |
|
|
2023
Q1 | $43K | Sell |
2,793
-10,143
| -78% | -$156K | ﹤0.01% | 2646 |
|
|
2022
Q4 | $212K | Buy |
12,936
+1,802
| +16% | +$29.5K | 0.01% | 1268 |
|
|
2022
Q3 | $206K | Sell |
11,134
-2,344
| -17% | -$43.4K | ﹤0.01% | 1910 |
|
|
2022
Q2 | $178K | Sell |
13,478
-5,267
| -28% | -$69.6K | ﹤0.01% | 1859 |
|
|
2022
Q1 | $174K | Sell |
18,745
-1,331
| -7% | -$12.4K | ﹤0.01% | 1836 |
|
|
2021
Q4 | $196K | Buy |
20,076
+16,717
| +498% | +$163K | ﹤0.01% | 1786 |
|
|
2021
Q3 | $114K | Buy |
3,359
+507
| +18% | +$17.2K | ﹤0.01% | 2289 |
|
|
2021
Q2 | $105K | Sell |
2,852
-1,893
| -40% | -$69.7K | ﹤0.01% | 2381 |
|
|
2021
Q1 | $213K | Buy |
4,745
+1,771
| +60% | +$79.5K | ﹤0.01% | 1960 |
|
|
2020
Q4 | $169K | Buy |
2,974
+918
| +45% | +$52.2K | 0.01% | 1854 |
|
|
2020
Q3 | $105K | Sell |
2,056
-276
| -12% | -$14.1K | ﹤0.01% | 3114 |
|
|
2020
Q2 | $139K | Buy |
+2,332
| New | +$139K | 0.01% | 2154 |
|
|
2020
Q1 | – | Sell |
-880
| Closed | -$55K | – | 4107 |
|
|
2019
Q4 | $55K | Buy |
880
+230
| +35% | +$14.4K | ﹤0.01% | 1285 |
|
|
2019
Q3 | $22K | Sell |
650
-2,213
| -77% | -$74.9K | ﹤0.01% | 2426 |
|
|
2019
Q2 | $64K | Buy |
+2,863
| New | +$64K | ﹤0.01% | 1450 |
|
|
2018
Q4 | – | Sell |
-51
| Closed | -$2K | – | 4495 |
|
|
2018
Q3 | $2K | Buy |
+51
| New | +$2K | ﹤0.01% | 3500 |
|
|
2018
Q2 | – | Sell |
-1,758
| Closed | -$35K | – | 4159 |
|
|
2018
Q1 | $35K | Buy |
1,758
+1,312
| +294% | +$26.1K | ﹤0.01% | 1889 |
|
|
2017
Q4 | $10K | Buy |
+446
| New | +$10K | ﹤0.01% | 2575 |
|